Skip to main content
Clinical Trials/NCT00519025
NCT00519025CompletedNot Applicable

Risk Factors for Linezolid Resistance in Staphylococcus Aureus

University of Pittsburgh1 site in 1 country360 target enrollmentStarted: August 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
360
Locations
1

Study Overview

Brief Summary

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.

Detailed Description

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed. This research is important because identification of risk factors may allow earlier initiation of appropriate therapy in patients infected with these bacteria. Additionally, we will identify whether horizontal spread is responsible for this increasing trend.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with linezolid resistance to staphylococcus aureus

Exclusion Criteria

  • those that don't meet entry criteria

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Brian Potoski

Assistant Professor

University of Pittsburgh

Study Sites (1)

Loading locations...

Similar Trials